<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01745029</url>
  </required_header>
  <id_info>
    <org_study_id>2012013250</org_study_id>
    <nct_id>NCT01745029</nct_id>
  </id_info>
  <brief_title>Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit</brief_title>
  <official_title>Gastrointestinal Motility in Patients Suffering From Severe Ulcerative Colitis Obtained by Motilis-3D-transit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Motilis Medica A/S ,Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe gastrointestinal (GI) motility in patients suffering&#xD;
      from severe Ulcerative Colitis (UC) and to compare these results with similar results&#xD;
      obtained in remission.&#xD;
&#xD;
      The study is done with the use of Motilis 3D-Transit system which consists of a small&#xD;
      electronic capsule ingested and detected by a receiver carried by the patient. Position and&#xD;
      orientation of the capsule are interpreted by dedicated computer software and transit times,&#xD;
      progression velocity and contraction frequencies can be revealed.&#xD;
&#xD;
      The study is mainly descriptive and is designed to test and evaluate the usefulness of the&#xD;
      Motilis 3D Transit system in UC patients and to tell investigators more about GI motility&#xD;
      during and after severe inflammation.&#xD;
&#xD;
      Motilis 3D-Transit system gives investigators a unique chance to study the gastrointestinal&#xD;
      canal as a whole during and after severe illness.&#xD;
&#xD;
      The investigators expect to include 20 patients suffering from severe UC admitted to Hospital&#xD;
      with the purpose of getting medical treatment. The investigators do not expect any drop out,&#xD;
      but in case of drop out a new patient will be included.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Velocity of progression through the inflamed part of the colon in severe UC compared to the velocity of progression in the corresponding colonic segment in quiescent UC.</measure>
    <time_frame>Three days from baseline visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Velocity of progression through the non-inflamed colonic segments in severe UC compared to the velocity of progression in the corresponding colonic segments in quiescent UC.</measure>
    <time_frame>Three days from baseline</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Velocity of progression through the colonic segments in quiescent UC compared to the velocity of progression in the corresponding colonic segments in healthy volunteers.</measure>
    <time_frame>three days from baseline visit</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Ulcerative Colitis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Motilis-3D-transit</intervention_name>
    <arm_group_label>Ulcerative Colitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from severe Ulcerative Colitis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Severe Ulcerative colitis (modified Truelove and Witt score)&#xD;
&#xD;
          -  Signed informed consent obtained&#xD;
&#xD;
          -  Fasted since midnight&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known GI related symptoms complaints or GI diseases&#xD;
&#xD;
          -  Swallowing disorders&#xD;
&#xD;
          -  Cancer or other life threatening diseases or conditions&#xD;
&#xD;
          -  Pregnancy or breast-feeding&#xD;
&#xD;
          -  Previous abdominal surgery&#xD;
&#xD;
          -  Abdominal diameter &gt;140cm?&#xD;
&#xD;
          -  Drug abuse or alcoholism&#xD;
&#xD;
          -  Irregular bowel movements&#xD;
&#xD;
          -  Known cardiovascular or pulmonary diseases&#xD;
&#xD;
          -  Participation in any clinical study within the last 30 days&#xD;
&#xD;
          -  Cardiac pacemaker or infusion pump or any other implanted or portable&#xD;
             electro-mechanical medical device.&#xD;
&#xD;
          -  Medication affecting GI motility&#xD;
&#xD;
          -  MRI within the next four weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>AnneMette Haase, ph.d student</last_name>
    <phone>+45 61658483</phone>
    <email>annemette.haase@ki.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Klaus Krogh, Professor</last_name>
    <phone>+45 2338 5937</phone>
    <email>klaukrog@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital, Department of Hepato and Gastroenterolegy</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AnneMette Haase, Ph.d Student</last_name>
      <phone>+45 6165 8483</phone>
      <email>annemette.haase@ki.au.dk</email>
    </contact>
    <investigator>
      <last_name>AnneMette Haase, Ph.d Student</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>December 6, 2012</study_first_submitted>
  <study_first_submitted_qc>December 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2012</study_first_posted>
  <last_update_submitted>January 6, 2014</last_update_submitted>
  <last_update_submitted_qc>January 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastrointestinal Motility</keyword>
  <keyword>Inflammatory Bowel Disease</keyword>
  <keyword>Transit time</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

